These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9169252)

  • 1. A comparative study of Ocusert Pilo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment of primary acute angle-closure glaucoma.
    Edwards RS
    Curr Med Res Opin; 1997; 13(9):501-9. PubMed ID: 9169252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma : a prospective, randomized, controlled trial.
    Lam DS; Lai JS; Tham CC; Chua JK; Poon AS
    Ophthalmology; 2002 Sep; 109(9):1591-6. PubMed ID: 12208703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pupillary, refractive, and hypotensive effects of Ocusert-40 and pilocarpine eyedrops in the treatment of chronic simple glaucoma.
    Smith SE; Smith SA; Friedmann AI; Chaston JM
    Br J Ophthalmol; 1979 Apr; 63(4):228-32. PubMed ID: 435437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilocarpine ocusert system for sustained control of ocular hypertension.
    Macoul KL; Pavan-Langston D
    Arch Ophthalmol; 1975 Aug; 93(8):587-90. PubMed ID: 1164218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ocusert pilocarpine on anterior chamber depth, visual acuity and intraocular pressure in man.
    Drance SM; Mitchell DW; Schulzer M
    Can J Ophthalmol; 1977 Jan; 12(1):24-8. PubMed ID: 849537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study.
    Jin X; Xue A; Zhao Y; Qin Q; Dong XD; Qu J
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1611-6. PubMed ID: 17437125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-acting Ocusert-pilocarpine system in the management of glaucoma.
    Lee P; Shen Y; Eberle M
    Invest Ophthalmol; 1975 Jan; 14(1):43-6. PubMed ID: 1110136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miotics in closed-angle glaucoma.
    Ganias F; Mapstone R
    Br J Ophthalmol; 1975 Apr; 59(4):205-6. PubMed ID: 1138844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma: a pilot study.
    Lam DS; Chua JK; Tham CC; Lai JS
    Ophthalmology; 2002 Jan; 109(1):64-70. PubMed ID: 11772581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical problems in the use of Ocusert-pilocarpine delivery system.
    Sihvola P; Puustjärvi T
    Acta Ophthalmol (Copenh); 1980 Dec; 58(6):933-7. PubMed ID: 7331779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duration of action of pilocarpine Ocusert on intraocular pressure in man.
    Drance SM; Mitchell DW; Schulzer M
    Can J Ophthalmol; 1975 Oct; 10(4):450-2. PubMed ID: 1192264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pilocarpine Ocusert: a new drug delivery system.
    Friederich RL
    Ann Ophthalmol; 1974 Dec; 6(12):1279-84. PubMed ID: 4440977
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pilocarpine Ocusert with different release rates on ocular pressure.
    Armaly MF; Rao KR
    Invest Ophthalmol; 1973 Jul; 12(7):491-6. PubMed ID: 4742991
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicentre study of the effect and tolerance of Ocusert-P-40.
    Akerblom T; Aurell E; Cristiansson J; Kriisa-Kunnos V; Wiebert O
    Acta Ophthalmol (Copenh); 1980 Aug; 58(4):617-23. PubMed ID: 7010885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ocusert pilocarpine system: advantages and disadvantages.
    Pollack IP; Quigley HA; Harbin TS
    South Med J; 1976 Oct; 69(10):1296-8. PubMed ID: 982104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute closed-angle glaucoma with miotics and timolol.
    Airaksinen PJ; Saari KM; Tiainen TJ; Jaanio EA
    Br J Ophthalmol; 1979 Dec; 63(12):822-5. PubMed ID: 526463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients].
    Novak-Laus K; Masnec-Paskvalin S; Korsić J; Iveković R; Zorić-Geber M; Mandić Z
    Acta Med Croatica; 2006; 60(2):113-6. PubMed ID: 16848200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilocarpine medication in open-angle glaucoma. A study using pilocarpine eyedrops and an ocular therapeutic system.
    Brinchmann-Hansen O; Anmarkrud N
    Acta Ophthalmol (Copenh); 1979 Feb; 57(1):55-62. PubMed ID: 419977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of pilocarpine upon the aqueous humour dynamics using ocusert with continuous delivery rate (author's transl)].
    Draeger J; Haselmann G; Weber B
    Klin Monbl Augenheilkd; 1975 Oct; 167(4):527-33. PubMed ID: 1206934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.